Bio-Gene Technology (ASX:BGT) Inventories, Raw Materials & Components: A$0.00 Mil (As of Dec. 2025)


What is Bio-Gene Technology Inventories, Raw Materials & Components?

Bio-Gene Technology ASX:BGT -15.00% Inventories, Raw Materials & Components is A$0.00 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Bio-Gene Technology's inventories, raw materials & components for the quarter that ended in Dec. 2025 was A$0.00 Mil.


Bio-Gene Technology Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Inventories, Raw Materials & Components Chart

Bio-Gene Technology Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Bio-Gene Technology Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of A$0.00 Mil mean?
Bio-Gene Technology (ASX:BGT) has a Inventories, Raw Materials & Components of A$0.00 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on Bio-Gene Technology and its competitors.
Is Bio-Gene Technology's Inventories, Raw Materials & Components too high?
Bio-Gene Technology's current Inventories, Raw Materials & Components is A$0.00 Mil.
How does Bio-Gene Technology's Inventories, Raw Materials & Components compare to VRTX and REGN?
Bio-Gene Technology's Inventories, Raw Materials & Components of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Inventories, Raw Materials & Components is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Inventories, Raw Materials & Components of A$0.00 Mil. The current Inventories, Raw Materials & Components is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Inventories, Raw Materials & Components is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.